Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
isopropyl alcohol + triamcinolone acetonide + dexamethasone sodium phosphate + bupivacaine
- Development stage
- Unknown
- Lead developer
- Merck
- Modality
- Small Molecules
- Administration
- Injection, Local Infiltration, Intraarticular, Intralesional
01
Overview
This appears to be a **multi-ingredient compounded pharmaceutical mixture** containing isopropyl alcohol, triamcinolone acetonide, dexamethasone sodium phosphate, and bupivacaine. Pharmacologically, the mixture combines two corticosteroids that act as **glucocorticoid receptor agonists** to suppress inflammatory gene transcription and reduce edema and immune-cell activity, together with **bupivacaine**, a local anesthetic that blocks voltage-gated sodium channels to provide analgesia. Isopropyl alcohol in this context most plausibly functions as a procedural antiseptic or solvent rather than as a therapeutic active ingredient. Based on the provided context, this specific four-component combination is not identifiable as a distinct standardized marketed drug product with a unique INN or well-established brand; the surrounding indication text instead matches general corticosteroid labeling and therefore does not specifically validate a unique development program for this exact combination.
- Other names
- isopropyl alcohol + triamcinolone acetonide + dexamethasone sodium phosphate + bupivacaine
02
Targets
NaV (Voltage-gated sodium channels)GR (Glucocorticoid receptor)
Beyond the preview
Go deeper on isopropyl alcohol + triamcinolone acetonide + dexamethasone sodium phosphate + bupivacaine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on isopropyl alcohol + triamcinolone acetonide + dexamethasone sodium phosphate + bupivacaine.